Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmela Di Gioia

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 27, 2019
Vaccinia Virus Genome Editing Using CRISPRCarmela Di Gioia, Ming Yuan, Yaohe Wang
Anticancer Research|August 1, 2018
Morphological Analysis of Amoeboid-Mesenchymal Transition Plasticity After Low and High LET Radiation on Migrating and Invading Pancreatic Cancer CellsAngelica Facoetti, Carmela DI Gioia, Francesca Pasi, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancerGiulia Marelli, Louisa S Chard Dunmall, Ming Yuan, et al.
Oncoimmunology|June 3, 2022
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapyRenato B Baleeiro, Christian J Bouwens, Peng Liu, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancerRenato Brito Baleeiro, Peng Liu, Louisa S Chard Dunmall, et al.
Frontiers in Immunology|January 22, 2025
A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancerLijuan Chen, Pengju Wang, Carmela Di Gioia, et al.
Frontiers in Immunology|March 20, 2026
Correction: A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancerLijuan Chen, Pengju Wang, Carmela Di Gioia, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|June 27, 2019
Vaccinia Virus Genome Editing Using CRISPRCarmela Di Gioia, Ming Yuan, Yaohe Wang
Anticancer Research|August 1, 2018
Morphological Analysis of Amoeboid-Mesenchymal Transition Plasticity After Low and High LET Radiation on Migrating and Invading Pancreatic Cancer CellsAngelica Facoetti, Carmela DI Gioia, Francesca Pasi, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancerGiulia Marelli, Louisa S Chard Dunmall, Ming Yuan, et al.
Oncoimmunology|June 3, 2022
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapyRenato B Baleeiro, Christian J Bouwens, Peng Liu, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancerRenato Brito Baleeiro, Peng Liu, Louisa S Chard Dunmall, et al.
Frontiers in Immunology|January 22, 2025
A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancerLijuan Chen, Pengju Wang, Carmela Di Gioia, et al.
Frontiers in Immunology|March 20, 2026
Correction: A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancerLijuan Chen, Pengju Wang, Carmela Di Gioia, et al.
Pageof 1